Regulation of cardiac remodeling by nitric oxide: focus on cardiac myocyte hypertrophy and apoptosis.
about
TGFβ receptor activation enhances cardiac apoptosis via SMAD activation and concomitant NO releaseWhole transcriptome analysis of the fasting and fed Burmese python heart: insights into extreme physiological cardiac adaptationOxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load.Electroacupuncture at PC6 (Neiguan) Improves Extracellular Signal-Regulated Kinase Signaling Pathways Through the Regulation of Neuroendocrine Cytokines in Myocardial Hypertrophic Ratsp90RSK targets the ERK5-CHIP ubiquitin E3 ligase activity in diabetic hearts and promotes cardiac apoptosis and dysfunction.Targeting calcineurin and associated pathways in cardiac hypertrophy and failure.Celecoxib prevents pressure overload-induced cardiac hypertrophy and dysfunction by inhibiting inflammation, apoptosis and oxidative stress.Roles of phosphodiesterases in the regulation of the cardiac cyclic nucleotide cross-talk signaling networkSabiporide reduces ischemia-induced arrhythmias and myocardial infarction and attenuates ERK phosphorylation and iNOS induction in rats.Effect of Berberine on PPAR α /NO Activation in High Glucose- and Insulin-Induced Cardiomyocyte Hypertrophy.Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failureAbsence of cytoglobin promotes multiple organ abnormalities in aged mice.Effects of MEK5/ERK5 association on small ubiquitin-related modification of ERK5: implications for diabetic ventricular dysfunction after myocardial infarction.Low-dose radiation prevents type 1 diabetes-induced cardiomyopathy via activation of AKT mediated anti-apoptotic and anti-oxidant effects.Novel therapeutic targets for the treatment of heart failure.Mechanisms of the cyclic nucleotide cross-talk signaling network in cardiac L-type calcium channel regulation.SERCA inhibition limits the functional effects of cyclic GMP in both control and hypertrophic cardiac myocytes.Intracellular growth of Trypanosoma cruzi in cardiac myocytes is inhibited by cytokine-induced nitric oxide release.Modulation of contractility by myocyte-derived arginase in normal and hypertrophied feline myocardium.Activation of extracellular signal-regulated kinase 5 reduces cardiac apoptosis and dysfunction via inhibition of a phosphodiesterase 3A/inducible cAMP early repressor feedback loop.K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.Reduction in interaction between cGMP and cAMP in dog ventricular myocytes with hypertrophic failure.Dronedarone produces early regression of myocardial remodelling in structural heart disease.Induction of different activated phenotypes of mouse peritoneal macrophages grown in different tissue culture media.Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.Antioxidant bilirubin works in multiple ways to reduce risk for obesity and its health complications
P2860
Q28571201-AEB2B7C8-E263-417C-97B0-E58035B96063Q33736492-4000F34D-A421-421C-B4E8-49110CD55A0EQ33743649-026908FA-DB36-43E0-B450-9A7066FFD9FBQ35184843-C45DB38C-71F7-4AF5-90F1-5D8B33B685A1Q35837423-DE11E4AF-E38C-47F7-B695-048511C07329Q36268310-08FDF1B3-F255-42DE-9A22-59D1B4104672Q36476890-5EAF5D10-E65C-43B0-BCE9-B6920236D5DEQ36609843-3726546C-A2E1-418A-B34A-1A04C2CD1839Q36665083-98098809-050F-4109-A2A8-13A08C12BDF3Q36739688-B7E51DEA-983C-45A2-AA8A-EA3F7E028E7FQ36745572-6C49AB22-F632-444E-A2CE-090A0E42B30DQ36870802-EF680175-8009-43C4-BEEE-FED00A5774E0Q37038236-413A33C6-424A-4FB7-B089-2B2A0DBBF7C9Q37056996-AECC4B08-2CC4-445D-BBB3-533005D826A6Q37893956-E7A40A9C-C8C9-4326-BEA4-284D7FABD097Q38862807-AAC102A6-DD85-4656-8BEB-6A4D69CAE49CQ39515221-6D2833EE-F453-44CD-8D41-8E8A8344BFA1Q40582579-CB6EAE73-6522-44FE-A2B9-EB4B76E89266Q42487357-F3C6682F-9CD3-4AFE-BA14-16A5D7B7B1AFQ42756844-4028B7C9-BCF8-4E2D-BAC8-962554B46C06Q46079299-317C0438-0575-4F9E-8E6F-0E9A79312059Q46650386-BBAAF5DB-F59D-411A-BB19-371895B6835DQ47169675-F62C78E6-3C18-4980-9FCE-508AB1FC71B4Q48174814-2BD00CDD-3FCF-47F2-8759-542AB5DA6EEBQ52694977-9DF5EF02-0657-4D92-9746-8C3B81411D04Q58558363-EFE18864-C5B3-431D-A221-7D6CA098A0E4
P2860
Regulation of cardiac remodeling by nitric oxide: focus on cardiac myocyte hypertrophy and apoptosis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Regulation of cardiac remodeli ...... yte hypertrophy and apoptosis.
@ast
Regulation of cardiac remodeli ...... yte hypertrophy and apoptosis.
@en
Regulation of cardiac remodeli ...... yte hypertrophy and apoptosis.
@nl
type
label
Regulation of cardiac remodeli ...... yte hypertrophy and apoptosis.
@ast
Regulation of cardiac remodeli ...... yte hypertrophy and apoptosis.
@en
Regulation of cardiac remodeli ...... yte hypertrophy and apoptosis.
@nl
prefLabel
Regulation of cardiac remodeli ...... yte hypertrophy and apoptosis.
@ast
Regulation of cardiac remodeli ...... yte hypertrophy and apoptosis.
@en
Regulation of cardiac remodeli ...... yte hypertrophy and apoptosis.
@nl
P356
P1476
Regulation of cardiac remodeli ...... yte hypertrophy and apoptosis.
@en
P2093
Helmut Drexler
Kai C Wollert
P2888
P304
P356
10.1023/A:1020706316429
P577
2002-10-01T00:00:00Z
P6179
1044893597